Author

Ellen J. Scherl 1

1 Weill Cornell Medicine, New York Presbyterian Hospital, New York, United States

CORTICOSTEROID-SPARING EFFECTS OF USTEKINUMAB THERAPY FOR ULCERATIVE COLITIS THROUGH 4 YEARS: UNIFI LONG-TERM EXTENSION

Ramesh P. Arasaradnam, Ellen J. Scherl, David Rowbotham, Silvio Danese, William J. Sandborn, Ye Miao, Hongyan Zhang, Remo Panaccione, Waqqas Afif, Tadakazu Hisamatsu, Rupert W Leong, Bruce E. Sands, Maria T. Abreu, Colleen W. Marano

Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 2 Years: UNIFI Long-term Extension

Bruce E. Sands, William Sandborn, Remo Panaccione, Christopher D. O'Brien, Hongyan Zhang, Jewel Johanns, Yiying Zhou, Ilia Tikhonov, Laurent Peyrin-Biroulet, Gert Van Assche, Silvio Danese, Stephan Targan, Maria T. Abreu, Tadakazu Hisamatsu, Ellen Scherl, Rupert W Leong, David Rowbotham, Ramesh P. Arasaradnam, Colleen W.

EFFICACY AND SAFETY OF USTEKINUMAB FOR ULCERATIVE COLITIS THROUGH 4 YEARS: FINAL RESULTS FROM THE UNIFI LONG-TERM EXTENSION

Waqqas Afif, Maria T. Abreu, Silvio Danese, William J. Sandborn, Ye Miao, Hongyan Zhang, Remo Panaccione, Tadakazu Hisamatsu, Ellen J. Scherl, Rupert W Leong, David Rowbotham, Ramesh P. Arasaradnam, Laurent Peyrin-Biroulet, Bruce E. Sands, Colleen W. Marano

EFFICACY OF USTEKINUMAB FOR ULCERATIVE COLITIS IN PATIENTS THROUGH 3 YEARS: UNIFI LONG-TERM EXTENSION

David Rowbotham, Maria T. Abreu, Silvio Danese, William J. Sandborn, Ye Miao, Hongyan Zhang, Remo Panaccione, Tadakazu Hisamatsu, Ellen Scherl, Rupert W Leong, Ramesh P. Arasaradnam, Waqqas Afif, Laurent Peyrin-Biroulet, Bruce E. Sands, Colleen W. Marano

Efficacy of Ustekinumab Subcutaneous Maintenance Treatment by Induction-Dose Subgroup in the UNIFI Study of Patients with Ulcerative Colitis

Silvio Danese, Bruce E. Sands, William Sandborn, Colleen W. Marano, Christopher D. O'Brien, Hongyan Zhang, Jewel Johanns, Laurent Peyrin-Biroulet, Ellen Scherl, Tadakazu Hisamatsu, Remo Panaccione

HIGHER ADALIMUMAB TROUGH LEVELS ARE ASSOCIATED WITH HISTOLOGIC REMISSION AND MUCOSAL HEALING

Rochelle Wong, Lihui Qin, Yushan Pan, Prerna Mahtani, Randy Longman, Dana Lukin, Ellen J. Scherl, Robert Battat

PREDICTIVE MODEL FOR OUTCOMES IN INFLAMMATORY BOWEL DISEASE PATIENTS ON MAINTENANCE INFLIXIMAB THERAPY

Rochelle Wong, Paris Charilaou, Amy Hemperly, Lihui Qin, Yushan Pan, Prerna Mahtani, Randy Longman, Brigid Boland, Parambir Dulai, Ariela Holmer, Dana Lukin, Siddharth Singh, Mark Valasek, William J. Sandborn, Ellen J. Scherl, Niels Vande Casteele, Robert Battat

THE PHARMACOKINETICS AND IMMUNOGENICITY OF USTEKINUMAB AND ADALIMUMAB IN PATIENTS WITH MODERATE-TO-SEVERE CROHN’S DISEASE: RESULTS FROM THE SEAVUE STUDY

Silvio Danese, James Izanec, Tony Ma, Omoniyi J. Adedokun, Christopher Gasink, Stephen B Hanauer, Ellen Scherl, Kamal Patel

Item 1 - 8 / 8
1